Genenta Science: Genenta Announces Pricing of Upsized Initial Public Offering

MILAN, Italy and NEW YORK, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Genenta Science S.p.A., a clinical-stage biotechnology company pioneering the development of hematopoietic stem progenitor cell immuno-gene

Related Keywords

New York ,United States ,Italy ,Milan ,Lombardia ,American ,Kostenloser Wertpapierhandel ,Stefania Mazzoleni ,Mary Ann Chang ,Maxim Group ,Syndicate Department ,American Depositary Shares ,Nasdaq Capital Market ,Capital Partners ,Registration Statement ,Roth Capital Partners ,Clemente Drive ,Newport Beach ,Equity Capital Markets ,Glioblastoma Multiforme ,Sci Advisors ,Ann Chang ,Genenta ,Science ,Nnounces ,Ricing ,Upsized ,Nitial ,Public ,Offering ,